Skip to main content

Novel selective mTORC1 inhibitors

Project description

Novel therapy for liver cancer could improve prognosis

Field of science

  • /medical and health sciences/clinical medicine/oncology/cancer
  • /medical and health sciences/clinical medicine/oncology/cancer/liver cancer

Call for proposal

ERC-2019-PoC
See other projects for this call

Funding Scheme

ERC-POC-LS - ERC Proof of Concept Lump Sum Pilot

Host institution

UNIVERSITAT BASEL
Address
Petersplatz 1
4051 Basel
Switzerland
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 150 000

Beneficiaries (1)

UNIVERSITAT BASEL
Switzerland
EU contribution
€ 150 000
Address
Petersplatz 1
4051 Basel
Activity type
Higher or Secondary Education Establishments